Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mucosal Immunol. 2014 Sep;7(5):1244-54. doi: 10.1038/mi.2014.14. Epub 2014 Mar 19.

Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection.

Author information

  • 1Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • 2Vaccinex, Inc. 1895 Mount Hope Avenue, Rochester, New York, USA.
  • 3Third Department of Internal Medicine, Kyorin University, Tokyo, Japan.
  • 4Kitasato Institute for Life Sciences and Graduate School of Infection Control Sciences, Tokyo, Japan.
  • 5Graduate School of Pharmaceutical Science, Kitasato University, Tokyo, Japan.
  • 61] Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan [2] The Integrated Center for Mass Spectrometry, Graduate School of Medicine, Kobe University, Kobe, Japan [3] Division of Metabolomics Research, Kobe University Graduate School of Medicine, Kobe, Japan.

Abstract

Helicobacter suis infects the stomachs of both animals and humans, and can induce gastric mucosa-associated lymphoid tissue (MALT) lymphomas. It is known that CXC chemokine ligand 13 (CXCL13) is highly expressed in the Helicobacter-infected mice and gastric MALT lymphoma patients, but the pathway that links the activation of CXCL13 and the formation of gastric MALT lymphomas remains unclear. In this study, we examined whether CXCL13 neutralization would interfere with the formation of gastric lymphoid follicles including B cells, CD4+T cells, dendritic cells (DCs), and follicular DCs (FDCs) in germinal centers to determine the role of CXCL13 in the formation of B-cell aggregates after H. suis infection. Moreover, the expression of genes associated with the lymphoid follicle formation was also effectively suppressed by anti-CXCL13 antibody treatment. These results suggest that the upregulation of CXCL13 has an important role in the development of gastric MALT lymphomas and highlight the potential of anti-CXCL13 antibody for protection against Helicobacter-induced gastric diseases.

PMID:
24646940
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk